Israel Englander Repligen Corp Put Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $179,685 - $251,025	1,500 Added 13.27%	12,800 $1.9 Million
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $324,000 - $493,964	2,700 Added 31.4%	11,300 $1.42 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $3.71 Million - $4.52 Million	-21,700 Reduced 71.62%	8,600 $1.58 Million
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $3.46 Million - $5.62 Million	30,300 New	30,300 $5.45 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $320,840 - $512,419	-2,000 Reduced 40.0%	3,000 $561,000

486

54.3M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.